College of Materials Science and Engineering, Fuzhou University, Fuzhou, 350108, China.
College of Chemistry, Fuzhou University, Fuzhou, 350108, China.
Curr Med Chem. 2024;31(21):3074-3092. doi: 10.2174/0929867330666230416153352.
Conventional tumor therapeutic modalities, such as radiotherapy, chemotherapy, and surgery, involve low tumor inhibition efficiency, non-targeted drug delivery, and side effects. The development of novel and practical nano-drug delivery systems (DDSs) for targeted tumor therapy has become particularly important. Among various bioactive nanoparticles, chitosan is considered a suitable candidate for drug delivery due to its nontoxicity, good biocompatibility, and biodegradability. The amino and hydroxyl groups of chitosan endow it with the diverse function of chemical modification, thereby improving its physical and biological properties to meet the requirements of advanced biomedical applications. Therefore, it is necessary to review the property and applications of chitosan- based materials in biomedicine. In this review, the characteristics of chitosan related to its applications are first introduced, and then the preparation and modification of chitosan-based nanoparticles, including the function tailoring of chitosan-modified nanoparticles, are demonstrated and discussed. Finally, the opportunities and challenges of chitosan- based nanomaterials in this emerging field are proposed from the perspective of the rational and systematic design for the biomedicine field.
传统的肿瘤治疗方法,如放疗、化疗和手术,存在肿瘤抑制效率低、靶向药物递送和副作用等问题。因此,开发新型实用的纳米药物递送系统(DDS)进行靶向肿瘤治疗变得尤为重要。在各种生物活性纳米粒子中,壳聚糖由于其无毒、良好的生物相容性和可生物降解性而被认为是一种合适的药物递送候选材料。壳聚糖的氨基和羟基使其具有化学修饰的多样性功能,从而改善其物理和生物性质,以满足先进生物医学应用的要求。因此,有必要对基于壳聚糖的材料在生物医学中的特性和应用进行综述。在本文综述中,首先介绍了与壳聚糖应用相关的特性,然后展示和讨论了基于壳聚糖的纳米粒子的制备和修饰,包括壳聚糖修饰纳米粒子的功能修饰。最后,从合理系统设计的角度出发,提出了基于壳聚糖的纳米材料在这一新兴领域的机遇和挑战。
Carbohydr Polym. 2021-11-15
Mini Rev Med Chem. 2017
Int J Biol Macromol. 2015-1
Biointerphases. 2016-12-25
Int J Biol Macromol. 2022-4-1
J Control Release. 2022-1
Chem Commun (Camb). 2021-9-28
Hematol Oncol. 2021-6
Adv Exp Med Biol. 2021
Macromol Biosci. 2021-5